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Different serotypes and evolutionary variants of human adenoviruses exhibit distinctive patterns of positive and negative
autoregulation of the viral E1A gene. An autoregulatory E1A promoter mutation of the adenovirus type 3 (Ad3) E1A gene
renders Ad3hr15 incapable of growth in normally permissive cells. The promoter mutation is complemented in trans by
E1A products of the heterologous helper adenovirus type 5 (Ad5). Second-site revertants of Ad3hr15 restore viability with
high levels of E1A gene expression. The revertant E1A genotypes retain the mutant E1A promoter and have small in-frame
deletions in the nonconserved region between the repression- and activation-associated conserved domains CR2 and CR3.
Plasmid expression vectors were constructed as 12S and 13S cDNA forms of revertant E1A genes. These were used in
cotransfection experiments with a reporter gene plasmid under transcriptional control of the mutant Ad3hr15 E1A promoter.
The repression of the Ad3hr15 E1A promoter by helper Ad5 or revertant 12S E1A cDNA was consistently greater than that
effected by wild-type Ad3 12S E1A cDNA expression. Significantly greater levels of positive transactivation were observed
in cotransfections with 13S cDNAs of Ad5 or with the 13S E1A cDNA of Ad3hr15 revertants, compared to the transactivation
observed with the mutant-encoded wild-type Ad3 13S E1A cDNA. The Ad5 helper and dl-revertant phenotype of Ad3hr15
appear to be related to transactivation activities of coexpressed E1A genes. The nonconserved region which separates the
conserved coding regions CR2 and CR3 of the type 3 E1A gene acts to attenuate E1A-mediated repression and transactivation
of transcription. q 1995 Academic Press, Inc.
Adenovirus E1A gene products encode a family of pro- dence indicates positive autoregulation elements within
upstream DNA sequences of E1A promoters (6, 37), al-teins that act as positive and negative transregulators of
viral and cellular genes, including the E1A gene itself though specific targets have not yet been identified. Con-
served, duplicate enhancer elements of adenovirus type(1–7). Two major forms of E1A gene products, denoted
12S and 13S, result from alternative donor sites in splic- 5 (Ad5) and adenovirus type 3 (Ad3) E1A promoters (38–
40) are plausible autorepression targets. The E1A en-ing of E1A gene transcripts (8, 9). A paradigm of E1A
gene structure–function characterizes the 12S gene hancer elements are essential for Ad5 E1A gene expres-
sion, yet they are dispensable for Ad3 E1A gene expres-products as repressors and the 13S gene products as
bifunctional repressor–activators. Each form interacts sion (2, 41).
Duplication of one of the nonessential Ad3 E1A en-with various transcription factors to indirectly influence
the regulatory functions of promoter-specific DNA se- hancer elements in mutant Ad3hr15 is a curiously lethal
lesion (42 – 44). The coding sequences of this mutant’squences (1, 10–23). Alignments of the E1A gene protein-
coding DNA sequences from different adenovirus sero- E1A gene are those of the wild-type Ad3. Wild-type Ad3
early E1A gene expression in permissive A549 cells ortypes reveal three conserved regions: CR1, CR2, and CR3
HeLa cells is very strong, especially compared with lev-(19, 24–27). CR1 and CR2 are represented in the mRNA
els observed with the more familiar laboratory prototypeof both 12S and 13S E1A forms and have been function-
Ad5. In contrast, infection of A549 cells or HeLa cellsally linked to transcriptional repression; CR3 is unique
by Ad3hr15 is abortive, and little if any Ad3-E1A geneto 13S E1A gene products and linked to transactivation
expression can be detected in these cells. The lethalof transcription (2, 19, 25–38).
phenotype of Ad3hr15 is overcome by heterologous Ad5Elements of the E1A promoter are phenotypic determi-
E1A gene expression in co-infected cells or in the Ad5nants of transcriptional autoregulation (7, 19, 26). Evi-
E1A gene-expressing 293 cell line. Revertants of
Ad3hr15 were isolated which regained the ability to1 To whom correspondence and reprint requests should be ad-
dressed. grow aggressively in A549 cells, in some cases ex-
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pressing even greater levels of their E1A genes than predicted to be less repressive of the Ad3hr15 E1A pro-
moter than the 12S cDNA products of the native Ad3wild-type Ad3 virus (44). These revertants retain the mu-
tant Ad3hr15 E1A promoter lesion and bear novel in- E1A gene. We have now examined this model using an
established approach of transient reporter gene expres-frame deletions within the coding region of their E1A
genes. The observed deletions of revertants dl7 and sion in transfected cell cultures.
We constructed a plasmid expression vector with thedl13 are 9 and 23 codons, respectively, and they overlap
in the nonconserved region between CR2 and CR3 (44). chloramphenicol transacetylase (CAT) reporter gene un-
der transcriptional control of the Ad3hr15 E1A promoter.It is of interest that the helper Ad5 E1A gene is shorter
by 16 codons in this nonconserved region, compared Except for the 60-bp duplication spanning the proximal
enhancer element (43), the plasmid is otherwise identicalwith the aligned DNA sequence of the Ad3 E1A gene
(24, 40, 44). to Ad3pE1ACAT described earlier (6, 37). It may be im-
portant to note that the 60-bp duplication sequence ofDuplication of a nonessential enhancer element of the
Ad3 E1A promoter in Ad3hr15 abrogates the mutant’s the Ad3hr15 E1A promoter (43) not only provides a third
enhancer element, but additional transcription factor rec-capacity for sustained E1A gene expression. Exacer-
bated autorepression was suggested to explain this mu- ognition sites, as for E2F (an inverted repeat and a single
copy) and AP1 (one copy). The duplicated sequencestant’s curious phenotype, based on the notion that the
triplet enhancer array would be a more susceptible re- are shown below in uppercase, and flanking native Ad3
sequences in lowercase. The left end of the duplicationpression target compared to the duplicate enhancer of
the parental Ad3 E1A promoter. The helper role of Ad5 disrupts (at the X) a native Ad3 BstNI restriction site,
displacing the site 60 bp further from the left end of theE1A gene products, compared with the native Ad3 E1A
products encoded by the mutant virus, was correlated viral genome. The position numbers refer to the native
Ad3 E1A promoter sequence, as base pairs from the leftwith the genotypes of second-site revertants (44). The
12S E1A products of Ad5 and Ad3hr15 revertants were end of the viral genome.
Duplicated 60 bp of Ad3hr15 E1A promoter
DdeI X DdeI
HinfI ----- HinfI BstNI
5*-ctgagtcatttcgcggttatgccCCATTTTCGCGCGAAAACTAAATGAGGAAGTGAATTTCTGAGTCATTTCGCGGTTATGCCagggtgg-3*
 
340 TTTCGCG AGGAAGTGAA TGAGTCA 341
CGCGAAA TTTCGCG
E2F 0200 enhancer AP1
E2F E2F
Figure 1A compares average levels of CAT gene prod- under control of the Ad3hr15 E1A promoter is signifi-
cantly greater in cells cotransfected with the 13S E1Auct (45) in cells cotransfected with the plasmids having
wild-type Ad3 or Ad3hr15 E1A promoters. The Ad3hr15 cDNA of helper virus Ad5 than in cells cotransfected with
the native Ad3 13S E1A cDNA.E1A promoter mutation does not appear to be a cis-
acting lesion with respect to transcription in transfected Thus we observe that the Ad3hr15 E1A promoter, with
its array of three E1A enhancer elements, supports highcells.
Figure 1B presents results of cotransfections of the levels of transcription in the absence of E1A gene prod-
ucts. In infected cells, where such transcription wouldAd3hr15 CAT vector, using the repressing 12S E1A cDNA
expression plasmids of Ad3 and Ad5 (39). These results generate wild-type Ad3 E1A gene products, little if any
transcription of the mutant’s E1A gene is sustained. Cellsindicate that the Ad3hr15 promoter is moderately more
susceptible to repression by the E1A products of its cotransfected with Ad3hr15 E1A-CAT and 12S E1A cDNA
plasmids, as native Ad3 or helper Ad5, show less CAThelper virus Ad5, than by the E1A products of its native
Ad3 coding sequences (Fig. 1B). This result is not consis- gene expression than cells transfected by the Ad3hr15
E1A-CAT plasmid alone. Cells cotransfected withtent with a model of Ad5 helper function for Ad3hr15
based on diminished repression of the Ad3hr15 E1A pro- Ad3hr15 E1A-CAT and 13S E1A cDNA plasmids, native
Ad3 or helper Ad5, show highly elevated levels of CATmoter (44).
Cotransfections of HeLa cells with the 13S cDNA ex- gene expression, compared to cells transfected by the
Ad3hr15 E1A-CAT plasmid alone.pression plasmids of Ad3 or Ad5 E1A genes (Fig. 1C)
show very high levels of trans-activation of the mutant Since the mutant promoter is repressed by the 12S
E1A cDNA of helper Ad5, and strongly transactivated byAd3hr15 E1A promoter. CAT reporter gene expression
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the 13S E1A cDNA of helper Ad5, we conclude that the the E1A genes of two Ad3hr15 revertants (dl7 and dl13)
revealed small in-frame deletions between CR2 andhelper phenomenon is based on autoregulatory trans-
activation, rather than diminished repression of the CR3, but otherwise parental Ad3 E1A DNA sequences
(44). The E1A gene of helper Ad5 is also shorter thanAd3hr15 E1A promoter.
The coding sequences of the Ad3hr15 E1A gene are the Ad3 DNA sequence in this region between CR2
and CR3.those of the wild-type Ad3 (43). Earlier sequencing of
Nonconserved coding domain between CR2 and CR3
of Ad3, Ad5, Ad3hr15 mutant and revertant E1A genes
RCR2 (nonconserved) CR3r
d113 DLRCYEEGFPPSDD ----------------------- FKLDCPELPGHGCKSC
Ad5 DLTCHEAGFPPSDD EDEE----------------GEE FVLDYVEHPGHGCRSC
dl7 DLRCYEEGFPPSDD EDGETE---------GVKAASDV FKLDCPELPGHGCKSC
Ad3 DLRCYEEGFPPSDD EDGTEEQSIHTAVNEGVKAASDV FKLDCPELPGHGCKSC
This suggests that the revertants’ E1A gene products vertant phenotypes. In contrast, the Ad3hr15 E1A pro-
moter is more strongly transactivated by revertant 13Smay be more functionally similar to those of the helper
E1A cDNA than by the wild-type Ad3 13S E1A cDNA.Ad5 than the parental Ad3, notwithstanding their other-
Transactivating activity which results from revertant 13Swise overt sequence similarity to the E1A products of
cDNA expression is functionally more similar to the E1AAd3. To investigate this, we constructed new 12S and
gene of the helper Ad5 than that of the native Ad3.13S E1A cDNA expression plasmids, representing
The enhancer elements of the adenovirus E1A pro-Ad3hr15 revertants dl7 and dl13 (deletions of 27 and 63
moter presumably play a role in early infection, to estab-bp, respectively) for use in cotransfection experiments
lish transcription complexes on infecting viral DNA tem-similar to those described in Fig. 1.
Transfections of HeLa cells were performed with
Ad3hr15 E1A-CAT, alone or together with the 12S cDNA
expression plasmids of native Ad3, revertant dl7, re-
vertant dl13, or helper Ad5 E1A genes. The helper Ad5
E1A and revertant E1A genes, as 12S cDNA forms, show
a consistently greater degree of repression of the
Ad3hr15 E1A promoter than the repression effected by
the native Ad3 12S cDNA (Fig. 2A). These results add to
the developing position that diminution of autorepression
is not a useful model to explain the helper or reversion
phenotypes of Ad3hr15. Deletions in the nonconserved
region between CR2 and CR3 are associated with greater
levels of enhancer-targeted autorepression.
Ad3hr15 E1A-CAT expression is strongly transacti-
vated in cells cotransfected with plasmids expressing
13S cDNAs of the revertant E1A genes (Fig. 2B). These
results support a revised model for the Ad3hr15 revertant
phenotypes, which emphasizes the functional similarity FIG. 1. Reporter gene expression from Ad3E1ACAT and Ad3hr15E1A-
of transactivating 13S cDNA activities of helper Ad5 and CAT in transfected or cotransfected HeLa cell cultures. Transfections
revertant E1A genes. were performed in suspensions of the HeLa cells with CaCl2 precipi-
tates of plasmid DNA (6, 37, 40, 45). One unit of CAT activity corre-In summary of these experiments, we do not observe
sponds to acetylation of 1% of substrate in 15 min at 377 under standarda remarkable susceptibility of the Ad3hr15 E1A promoter
assay conditions. Each experiment was performed at least five times
to repression or a diminished level of repression effected in triplicate. In some experiments the variance of CAT activity is too
by expression of revertant 12S cDNA genes, compared small to show error bars (standard error of the mean), in which case
a dot is placed above the corresponding column. (A) Ad3hr15CAT andto native Ad3 12S E1A cDNA. We do not ignore possibly
Ad3CAT alone. (B) Ad3hr15CAT cotransfected with Ad3 and Ad5 12S-significant variation of the levels of repression effected
expressing plasmids. (C) Ad3hr15CAT cotransfected with Ad3 and Ad5by the different forms of the Ad3 12S E1A cDNA genes. 13S-expressing plasmids. Notice the change in scale in (C) to reflect
However, these levels are consistently in the opposite the significantly higher levels of CAT gene expression from the 13S-
responsive Ad3hr15 promoter.direction to account for the Ad3hr15-Ad5 helper or re-
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Ad3hr15 and its revertants. The triplet enhancer array
of the mutant promoter supports an early transcription
complex which is not readily transformed (transactivated)
by the native Ad3 13S cDNA product. The helper Ad5
and revertant Ad3 E1A genes encode 13S cDNA products
which have altered juxtapositions of the conserved func-
tional domains CR2 and CR3, compared with the native
Ad3 13S cDNA product. These subtle alterations appear
to modulate activity of the 13S E1A products on the mu-
tant Ad3hr15 E1A promoter.
We remarked earlier (44) upon the correlation of the
variable sequence length between CR2 and CR3 of E1A
gene coding sequences and the oncogenic potential of
adenoviruses of different subgroups. More recent stud-
ies have mapped functional and genetic determinants
of adenovirus oncogenicity to the nonconserved region
between domains CR2 and CR3 in the subgroup A ade-
novirus Ad12 (46–48). Point mutations in this region af-
fect the oncogenicity of the virus. A small peptide en-
coded by this region appears to modulate the transcrip-
tion repression activity of cellular cJun/Ap-1 gene
products. Transcription of class I major histocompatibility
antigens is repressed by Ad12 E1A products, although
in this case Ad5 E1A products do not appear to interfere
with the repression (49).
The coincidence of mapping phenotypic and genetic
determinants to this nonconserved domain of the adeno-
virus E1A gene invites speculation about the transcrip-
tional modulation activity associated with this region. The
peptide structure encoded by this region may play a spe-
cific role, perhaps as a binding site for another (cellular)
factor which may inhibit transcription from a target gene
promoter. Indeed cellular transcription activators areFIG. 2. Ad3hr15E1ACAT expression in HeLa cells cotransfected with
known, for example, ADR1, which possess repressor re-plasmids expressing the 12S and 13S cDNA forms of wild-type and
revertant E1A genes. The cDNA clones of the Ad3hr15 revertants were gions between activating functional domains (50). This
constructed using mRNA from revertant-infected cells as substrates for region may encode another specific transcriptionally reg-
reverse transcription and PCR amplification. PCR amplification primers ulating product (not 12S or 13S). This has shown to beused by Cogan et al. (39) conveniently bracket the deleted sequences
the case for the corresponding nonconserved region inof the revertants’ E1A genes. (A) Revertant and helper Ad5 12S cDNA
Ad 12 (46). Another possibility is that the nonconservedcotransfections show levels of Ad3hr15E1ACAT expression which are
marginally to significantly greater than the repression effected by the region acts as a simple spacer, helping to juxtapose
wild-type Ad3 12S cDNA gene. (B) Transactivation of Ad3hr15E1ACAT the conserved domains, CR2 and CR3, at an optimum
by the 13S cDNA forms of the revertants is similar to levels obtained distance and orientation with respect to each other.with 13S cDNA expression of helper Ad5 E1A and significantly greater
These mechanisms are not mutually exclusive and maythan the transactivation observed with cotransfecting 13S cDNA of the
separately be important in the context of different targetnative Ad3 E1A gene.
promoters or in the functions of E1A products of different
adenovirus subgroups.
Further clarification of these issues awaits the devel-plates. The early products of E1A gene expression return
to infected cell nuclei to act on these enhancer-mediated opment of effective in vitro assays which recapitulate
E1A gene transcriptional transregulation and autoregula-E1A gene transcription complexes. A major role of the
13S cDNA products of early E1A gene expression may tion. Functional cDNA-specific forms of native E1A pro-
teins for such assays, representing the E1A gene prod-be to transform these complexes from an enhancer-de-
pendent, repressible state to an enhancer-independent, ucts of Ad3, Ad5, and Ad3hr15 and its revertants, have
yet to be purified and characterized. In this shortfall oftransactivated state of transcription. Such a transforma-
tion of the E1A transcription complex is proposed to ex- methodology, we have constructed additional site-di-
rected variants of Ad3 cDNA expression plasmids, toplain the aberrant autoregulatory phenotypes of mutant
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